ALL KEYWORDSSarcoma GenomicsRelated SpecialistsShowing 3 of 23Raffaella MorottiMDJuan VasquezMDFarzana PashankarMD, MBBSMore Related SpecialistsRelated Fact SheetsDiagnosing Pediatric SarcomasRelated Clinical TrialsShowing 2 of 3A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib in Participants ≥18 Years of Age With Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment RegimenSarcoma CancersGender:All GendersAge:18 years and olderA First-In-Human, Phase 1, Dose Escalation Study of SGR-3515 In Participants With Advanced Solid TumorsPhase 1 CancersMore Related Clinical TrialsRelated NewsFamily HealthRelated DepartmentsShowing 3 of 25Internal MedicineCenter for Thoracic CancersHead & Neck Cancers ProgramMore Related Departments
